Efficacy of Raloxifen in treatment of fibromyalgia in menopausal women

European Journal of Internal Medicine

Volumn 19, Issue 5, 2008, Pages 350-355

  Sadreddini, Shahram ^a   Molaeefard, Mahshid ^b   Noshad, Hamid ^a   Ardalan, Mohamadreza ^a   Asadi, Amirhossein ^c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Sari pharmaceutical university   (Iran)

Author keywords

Fibromyalgia; Health Assessment Questionnaire (HAQ); Hospital Anxiety and Depression (HAD); Menopause; Raloxifen

Indexed keywords

ESTROGEN; PLACEBO; RALOXIFENE;

ADULT; AGED; ANXIETY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIZZINESS; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; FIBROMYALGIA; FLUSHING; HEADACHE; HEALTH ASSESSMENT QUESTIONNAIRE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; LEG CRAMP; MAJOR CLINICAL STUDY; MENOPAUSE; MUSCLE FATIGUE; NAUSEA; NIGHT SLEEP; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; VISUAL ANALOG SCALE; WEIGHT GAIN;

ADULT; AGED; DOUBLE-BLIND METHOD; ESTROGEN ANTAGONISTS; FEMALE; FIBROMYALGIA; HUMANS; MENOPAUSE; MIDDLE AGED; PAIN MEASUREMENT; QUESTIONNAIRES; RALOXIFENE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 44649126133     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2007.10.006     Document Type: Article

References (43)

1. Goldenberg D.L. Fibromyalgia syndrome: an emerging but controversial condition. JAMA 257 (1987) 2782-2787
2. Bennet R.M. Fibromyalgia: the commonest cause of widespread pain. Compr Ther 21 (1995) 269-275
3. Moldofsky H., Searisbrick P., England R., and Smythe H. Musculoskeletal symptoms and non-REM sleep disturbances in patients with fibrositis syndrome and healthy subjects. Psychosom Med 37 (1975) 341-351
4. Moldofsky H. Chronobiological influences on fibromyalgia syndrome: theoretical and therapeutic implications. Ballieres. Clin Rheumatol 8 (1994) 801-810
5. Cohen M.L., and Quintner J.L. Fibromyalgia syndrome, a problem of tautology. Lancet 342 (1993) 906-909
6. Benett R.M. Confounding features of the fibromyalgia syndrome, a current perspective of differential diagnosis. J Rheumatol 19 (1989) 58-61
7. Wolfe F. The fibromyalgia syndrome: a consensus reports on fibromyalgia and disability. J Rheumatol 16 (1996) 185-191
8. Bohr T.W. Fibromyalgia syndrome and myofascial pain syndrome do they really exist?. Neurol Clin 13 (1995) 265-284
9. Wolfe F., Smythe H.A., Yunus M.B., and Bennett R.M. The American College of Rheumatology (1990) criteria for the classification of fibromyalgia. Arthritis Rheum 33 (1990) 160-172
10. Marder W.D., Meenan R.F., Felson D.T., Reichin M., Birnbaum N.S., Croft J.D., et al. The present and future adequacy of rheumatology manpower: a study of healthcare needs and physician supply. Arthritis Rheum 34 (1991) 1209-1217
11. MacFarlane G.J., Morris S., Hunt I.M., Benjamin S., McBeth J., Papageorgiou A.C., et al. Chronic widespread pain in the community: the influence of psychological symptoms and mental disorders on healthcare seeking behaviour. J Rheumatol 26 (1999) 413-419
12. McCain G.A., Bell D.A., Mai F.M., and Halliday P.D. A controlled study of the effects of a supervised cardiovascular fitness-training program on the manifestations of primary fibromyalgia. Arthritis Rheum 331 (1988) 1135-1141
13. Burckardt C.S., Mannerkorpi K., Hedenberg L., and Bjelle A. A randomised controlled clinical trial of education and physical training for women with fibromyalgia. J Rheumatol 21 (1994) 714-720
14. Horven Wigers S., Stiles T.C., and Vogel P.A. Effects of aerobic exercise versus stress management treatment in fibromyalgia. Scand J Rheumatol 25 (1996) 77-86
15. Martin L., Nutting A., Macintosh B.R., Edworthy S.M., Butterwick D., and Cook J. An exercise program in the treatment of fibromyalgia. J Rheumatol 23 (1996) 1050-1053
16. Bandura A. Self efficacy mechanism in physiological activation and health promotion. In: Madden J, Matthysse S, Barchas J, editors. Adoption Learning and Affect. New York: Raven Press; 1991.
17. Lorig K., Chastain R.L., Ung E., Shoor S., and Holman H.R. Development and evaluation of a scale to measure perceived self-efficacy in people with arthritis. Arthritis Rheum 32 (1989) 37-44
18. Yunus M., Masi A.T., and Aldag J.C. Short term benefits of ibuprofen in primary fibromyalgia syndrome: a double blind placebo controlled trial. J Rheumatol 16 (1989) 527-532
19. Goldenberg D.L., Felson D.T., and Dinerman H. A randomised controlled trial of amytriptyline and naproxen in the treatment of fibromyalgia syndrome. Arthritis Rheum 29 (1986) 1371-1377
20. Biasi G., Manca S., Manganelli S., and Marcolongo R. Tramadol in the fibromyalgia syndrome: a controlled clinical trial versus placebo. Int J Clin Pharmacol Res 8 (1998) 13-19
21. Carrette S., Mccain G.A., Bell D.A., and Fam A.G. Evaluation of amitriptyline in fibrositis: a double blind placebo controlled study. Arthritis Rheum 29 (1986) 655-659
22. Jaeschke R., Adachi J., Guyatt G., Keller J., and Wong B. Clinical usefulness of amitriptyline in fibromyalgia: the results of 23 N-of-1 randomized controlled trials. J Rheumatol 18 (1991) 447-451
23. Barnes C.D., Fung S.J., and Gintautus J. Brainstem noradrenergic system depression by cyclobenzaprine. Neuropharmacology 19 (1980) 221-224
24. Bennett R.M., Gatter R.A., Campbell S.M., Andrews R.P., Clark S.R., and Scarola J.A. A comparison of cyclobenzaprine and placebo in the management of fibrositis. A double blind controlled study. Arthritis Rheum 31 (1988) 1535-1542
25. Carrette S., Bell M.J., Reynolds W.J., Haraoui B., McCain G.A.., Bykerk V.P., et al. Comparison of cyclobenzaprine, amitriptyline and placebo in fibromyalgia: a randomised double blind clinical trial. Arthritis Rheum 37 (1994) 32-40
26. Cortet B., Houvenagel E., Forzy G., Vincent G., and Delcambre B. Evaluation of the effectiveness of serotonin (fluoxetine hydrochloride) treatment. Open study in fibromyalgia. Rev Rhum Mal Osteo-artic 59 (1992) 497-500
27. Wolfe F., Cathey M.A., and Hawley D.J. A double-blind placebo controlled trial of fluoxetine in fibromyalgia. Scand J Rheumatol 23 (1994) 255-259
28. Vercoulen J.H., Swanink C.M., Zitman F.G., Vreden S.G., Hoofs M.P., Fennis J.F., et al. Randomised double blind placebo controlled study of fluoxetine in chronic fatigue syndrome. Lancet 347 (1996) 8858-8861
29. Baraczka K., Janko Z., Vargha K., and Markus H. Clinical experiences with the analgesic effects of citalopram. Orv Hetil 138 (1997) 2605-2607
30. Norregaard J., Volkmann H., and Danneskiold-Samsoe B. A randomized controlled trial of citalopram in the treatment of fibromyalgia. Pain 61 (1995) 445-449
31. Goldenberg D., Mayskiy M., Mossey C., Ruthazer R., and Schmid C. A randomized, double blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum 39 (1996) 1852-1859
32. Berman B.M., Ezzo J., Hadhazy V., and Swyers J.P. Is acupuncture effective in the treatment of fibromyalgia?. J Fam Pract 48 (1999) 213-218
33. Haanen H.C., Hoenderos H.T., Van Romunde L.K., and Hop W.C. Controlled trial of hypnotherapy in the treatment of refractory fibromyalgia. J Rheumatol 1 (1991) 72-75
34. Nicassio P.M., Schuman C., Kim J., Cordova C., and Weisman M. Psychosocial factors associated with complementary treatment use in fibromyalgia. J Rheumatol 24 (1997) 2008-2013
35. Nina H.B. Differential effects of alternatives to hormone replacement therapy in postmenopausal healthy women. Dan Med Bull 52 (2005) 64-81
36. Delmas P., Bruce H., Anne-Catherine R., Ravoux A.C., Shah A.S., Huster W.J., et al. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med 337 (1997) 1641-1647
37. Yaping J.i., Anne Z.M., and Richard J.T. Estrogen modulates the visceromotor reflex and responses of spinal dorsal horn neurons to colorectal stimulation in the rat. J Neurosci 23 9 (2003) 3908
38. Fries J.F., Spitz P., Kraines R.G., and Holman H.R. Measurement of patient outcome in arthritis. Arthritis Rheum 23 (1980) 137-145
39. Montazeri A., Vahdaninia M., Ebrahimi M., and Jarvandi S. The hospital anxiety and depression scale (HAD), translation and validation study of the Iranian version. Health Qual of Life Outcomes 1 (2003) 14
40. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale: a review of validation data and clinical results. J Psychosom Res 42 (1997) 17-41
41. Bjelland I., Dahl A.A., Tangen Haug T., and Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res 52 (2002) 69-77
42. Baumgartner E., Finckh A., Cedraschi C., and Vischer T.L. A six-year prospective study of a cohort of patients with fibromyalgia. Ann Rheum Dis 61 (2002) 644-645
43. Pioro-Boisset M., Esdaile J.M., and Fitzcharles M.A. Alternative medicine use in fibromyalgia syndrome. Arthritis Care Res 9 (1996) 13-17